search Search

More choice for you: Dexcom G7 with myLoop

myLoop, powered by CamAPS FX, will be available by Winter 2026, with the Dexcom G7 CGM system.

This integration expands the myLoop ecosystem and supports adaptive and flexible care for people living with type 1 diabetes.

Key information

  • Dexcom G7 will be available by Winter 2026 with myLoop. More information will be shared closer to the launch. 

  • As Dexcom has begun the phase-out of Dexcom G6, we recommend transitioning patients, if suitable, at the earliest opportunity. 

  • For now, Dexcom G6 remains fully supported. 

  • Seamless integration backed by mylife Diabetes Care, Dexcom and CamDiab. 

  • Training and clinical resources to support safe implementation. 

Training & resources

The following materials will be available to support clinical use and patient transition:

  • A short guide on how to transition to Dexcom G7

  • A detailed step-by-step guide

Frequently Asked Questions

Contact & support

Dexcom enquiries: Contact your local Dexcom representative or Dexcom Customer Support

CamAPS FX enquiries: Contact your local mylife Customer Service team

Disclaimer: The product images are for illustrative purposes only. mylife and YpsoPump are registered trademarks of mylife Diabetes Care or of its affiliates. CamAPS is a registered trademark of CamDiab Ltd. Dexcom and Dexcom G7 are registered trademarks of Dexcom, Inc. in the United States and/or other countries. Connectivity will vary by country. Smart device sold separately. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by mylife Diabetes Care is under license. Other trademarks are the property of their respective owners. For safety information on the products mentioned, see mylife-diabetescare.com.au/safety